134473-73-7

Basic information

• Product Name: 1-Benzyl-3-methoxy-piperidin-4-one
• Synonyms: 1-Benzyl-3-methoxy-piperidin-4-one;4-Piperidinone, 3-methoxy-1-(phenylmethyl)-
• CAS NO: 134473-73-7
• Molecular Formula: C₁₃H₁₇NO₂
• Molecular Weight: 219.27958
• Mol File: 134473-73-7.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-Benzyl-3-methoxy-piperidin-4-one(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Benzyl-3-methoxy-piperidin-4-one(134473-73-7)
• EPA Substance Registry System: 1-Benzyl-3-methoxy-piperidin-4-one(134473-73-7)

Safety Data

• Hazardous Substances Data: 134473-73-7(Hazardous Substances Data)

Usage

General Description

1-Benzyl-3-methoxy-piperidin-4-one is a chemical compound that belongs to the class of piperidinones. It is commonly used as an intermediate in the synthesis of pharmaceutical drugs and other organic compounds. It is known for its potential biological and pharmacological activities, including its ability to interact with the central nervous system. The compound has also been studied for its potential use in the treatment of various medical conditions. Its structure consists of a piperidinone ring with a benzyl group and a methoxy group attached to it, making it a versatile building block for the synthesis of new compounds with potential therapeutic properties. Additionally, it is important to handle and store this chemical with care, as it may pose risks to human health and the environment if not properly managed.

Upstream product

• 127364-15-2 1-phenylmethyl-3-methoxy-4,4-dimethoxypiperidine 

Downstream Products

• 86717-81-9 (cis+trans)-3-methoxy-1-(phenylmethyl)-4-piperidinamine 

Relevant articles and documents

PYRIMIDINONE DERIVATIVES AND METHODS OF USE THEREOF

The present invention relates to Pyrimidinone Derivatives, compositions comprising a Pyrimidinone Derivative, and methods of using the Pyrimidinone Derivatives for treating or preventing obesity, diabetes, a metabolic disease, a cardiovascular disease or a disorder related to the activity of GPR119 in a patient.

N-aryl-N-(1-substituted-3-alkoxy-4-piperidinyl)amides and pharmaceutical compositions and methods employing such compounds

This invention pertains to novel N-aryl-N-[N-substituted 3-alkoxy-4-piperidinyl]amides useful as analgesics, and methods of administering analgesia, which comprises the systemic administration to mammals of such compounds, and pharmaceutical compositions containing such compounds, wherein the novel compounds have the general formula: STR1 including optically active isomeric forms, cis/trans isomeric forms and the pharmaceutically acceptable acid addition salts therof, wherein: R is an aryl group selected from the group consisting of phenyl and substituted phenyl, wherein the substituents on the phenyl group are independently selected from the group consisting of halogen, lower-alkyl, lower-alkoxy, and combinations thereof; R1 is an alkyl group selected from the group consisting of lower-alkyl, lower-alkenyl, and lower-alkoxy lower-alkyl, each alkyl group having from 1 to 6 carbon atoms; R2 is a member selected from the group consisting of phenyl lower-alkyl, thienyl lower-alkyl, pyrazolyl lower-alkyl, tetrazolyl lower-alkyl, 4,5-dihydro-5-oxo-1H-tetrazolyl lower-alkyl, 1,3-dihydro-1,3-dioxo-2H-isoindolyl lower-alkyl, and 2,3-dihydro-2-oxo-1H-benzimidazolyl lower-alkyl; and R3 is a member selected from the group consisting of hydrogen, lower-alkyl and lower-alkyl aryl.